Axis-Shield partially settles homocysteine dispute
This article was originally published in Clinica
Executive Summary
Axis-Shield has reached a settlement with one of the companies it is suing for alleged infringement of its homocysteine patents. Under the out-of-court deal with Catch, of Bothell, Washington, the Anglo-Norwegian diagnostics group gains royalty-based access to Catch's detection technology and will receive royalties from Catch in return for allowing the US company to continue supplying its equipment to certain customers.